-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
China Pharma Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- China Pharma Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.09M, a 52.1% decline year-over-year.
- China Pharma Holdings, Inc. annual Operating Income (Loss) for 2023 was -$2.75M, a 22.5% increase from 2022.
- China Pharma Holdings, Inc. annual Operating Income (Loss) for 2022 was -$3.55M, a 24.1% decline from 2021.
- China Pharma Holdings, Inc. annual Operating Income (Loss) for 2021 was -$2.86M, a 10.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)